HCA Healthcare, Inc.
No SEC Form 4 filings for $HCA in the last 30 days.
See all $HCA insider activity →HCA Healthcare announced that Dale Neely, CEO of HCA Florida Capital Hospital, will resign effective October 23. Neely was appointed CEO in May 2025 after previously serving as COO from 2007 to 2012. The company expressed appreciation for his service.
HCA Houston Healthcare Kingwood named Chase Christianson as its new CEO, according to an Oct. 15 news release. Christianson previously served as CEO at HCA Florida Gulf Coast Hospital and other roles within HCA Healthcare. Officials highlighted his experience in operational growth and service expansion.
HCA Healthcare (HCA) reported Q2 revenue of $20.23B, up 8.7% YoY, exceeding estimates by 2.4%. Tenet Healthcare (THC) saw revenue of $5.63B, up 6.8%, beating estimates by 3.9%. Universal Health Services (UHS) reported $4.64B, up 8.3%, exceeding estimates by 1.1%. Acadia Healthcare (ACHC) reported $865.8M, flat YoY, topping estimates by 2%. HCA and Tenet stocks rose 24.5% and 34.3% post-earnings, respectively, while Acadia fell 5%.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning HCA (HCA Healthcare, Inc.). Coverage has skewed bearish: 0 bullish, 2 neutral, and 1 bearish.
Recent HCA coverage spans financial news and regulation.
The resignation may create short-term uncertainty and modest downside pressure on the stock.
The appointment is a localized executive change with limited impact on the broader HCA Healthcare stock.
The earnings beat is already reflected in the stock's 24.5% gain; little further upside expected today.
The new facility expands HCA's footprint in Florida, likely providing modest revenue uplift.
Analyst rating reinforcement may support modest upside pressure.
AlphAI scores every news story that mentions HCA with an AI model for sentiment and relevance, and aggregates insider trades from HCA Healthcare, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
HCA Healthcare announced that Dale Neely, CEO of HCA Florida Capital Hospital, will resign effective October 23. Neely was appointed CEO in May 2025 after previously serving as COO from 2007 to 2012. The company expressed appreciation for his service.
1 min readHCA Houston Healthcare Kingwood named Chase Christianson as its new CEO, according to an Oct. 15 news release. Christianson previously served as CEO at HCA Florida Gulf Coast Hospital and other roles within HCA Healthcare. Officials highlighted his experience in operational growth and service expansion.
1 min readHCA Healthcare (HCA) reported Q2 revenue of $20.23B, up 8.7% YoY, exceeding estimates by 2.4%. Tenet Healthcare (THC) saw revenue of $5.63B, up 6.8%, beating estimates by 3.9%. Universal Health Services (UHS) reported $4.64B, up 8.3%, exceeding estimates by 1.1%. Acadia Healthcare (ACHC) reported $865.8M, flat YoY, topping estimates by 2%. HCA and Tenet stocks rose 24.5% and 34.3% post-earnings, respectively, while Acadia fell 5%.
3 min readHCA Florida Lehigh Hospital opened a new freestanding ER in south Lee County, Florida, on Oct. 12. The facility features 11 exam rooms and on-site diagnostics. HCA announced a $134.5M investment in Lee County in 2025, including this ER and two others. In August, HCA revealed plans for a $300M hospital in Cape Coral, set to open in 2029.
2 min readCantor Fitzgerald reiterated an Overweight rating and $525 price target for HCA Healthcare (HCA), citing stable labor conditions and strong psychiatry segment performance. The company reported 7.3% revenue growth to $78 billion over the last twelve months. Analysts have mixed outlooks, with price targets ranging from $426 to $495, and ratings from Buy to Market Perform.
1 min readThe FTC sent letters to 24 major healthcare companies, including HCA Healthcare, Tenet Healthcare, Community Health Systems, and Universal Health Services, warning them to provide accurate and timely pricing information to patients. The FTC emphasized that deceptive pricing practices are prohibited, and companies must comply with transparency regulations.
1 min readHCA Healthcare and Mission Hospital have reached an 'agreement in principle' to settle an antitrust lawsuit accusing them of anticompetitive practices that increased healthcare costs in western North Carolina. The lawsuit, filed in 2021, alleged that HCA used Mission's regional monopoly to force insurers into contracts that raised insurance costs by 50-60%. The settlement details are not yet public, and the case is ongoing.
2 min readCantor Fitzgerald reiterated an Overweight rating and $525 price target for HCA Healthcare, citing undervaluation and strong admissions growth. Analysts have mixed outlooks, with some lowering targets due to challenges like HIX dynamics and softer surgical volumes, while others highlight growth drivers like investments in favorable geographies. HCA Healthcare faces headwinds from Florida funding roll-offs and health insurance exchange impacts.
2 min readBMO Capital initiated coverage of HCA Healthcare (HCA) with an Outperform rating and $495 price target, citing investments in high-growth markets and efficiency gains. HCA reported Q2 2026 revenue of $20.230 billion, up 8.7% YoY, and Adjusted EBITDA of $4.027 billion, up 4.6%. Challenges include payer mix shifts and high debt. BMO expects 4-6% EBITDA CAGR despite macroeconomic pressures.
3 min readAnalysts made several calls: UBS initiated CoreWeave as Buy with a $120 PT (~40% upside), KeyBanc initiated Guardian Pharmacy as Overweight, Wolfe raised Amazon's PT to $320, BMO initiated HCA Healthcare as Outperform, Morgan Stanley reiterated SpaceX as Overweight, Wells Fargo initiated Beta Bionics as Overweight with a $28 PT, Oppenheimer initiated Teva as Outperform with a $50 PT, Bernstein initiated Amphenol and TE Connectivity as Outperform, Rosenblatt reiterated Palantir as Buy, UBS…
3 min read
